Literature DB >> 10233482

Management of renal angiomyolipoma: a report of 53 cases.

S De Luca1, C Terrone, S R Rossetti.   

Abstract

OBJECTIVE: To evaluate the clinical, therapeutic and prognostic aspects of renal angiomyolipoma (AML) in patients either monitored by clinical and radiological follow-up or treated by surgical therapy. PATIENTS AND METHODS: Fifty-three patients with renal AML were divided in two groups; 33 patients in group 1 were monitored by annual clinical and ultrasonographic follow-up and 20 in group 2 were treated with surgical therapy. Two patients had tuberous sclerosis (TS) with synchronous bilateral and multiple lesions. Apart from the patients with TS, there were 38 lesions in group 1 and 25 in group 2. The mean (range) follow-up of group 1 was 60.2 (12-164) months.
RESULTS: In group 1, the diagnosis was most often incidental, after ultrasonography performed for symptoms unrelated to AML. In group 2, the suspicion of a malignant renal lesion, and spontaneous tumour rupture with bleeding and perirenal haematoma, were the main indications for surgical treatment. The mean lesion diameter was significantly greater in group 2 (5.4 cm) and in symptomatic patients (8.1 cm). In group 1, 92% of renal AMLs showed no radiographic changes, serious complications or new renal or extrarenal lesions during the follow-up. Only three lesions grew, after 22, 85 and 164 months, respectively. Of the 20 patients in group 2, 14 underwent conservative surgery.
CONCLUSION: Small (<4 cm) isolated AMLs, detected incidentally, showed a low risk of developing during long-term follow-up. Such patients may be followed conservatively by ultrasonography every 2 years. Spontaneous perinephric haemorrhage is related to the size of the lesion. When surgery is indicated (by symptoms or diagnostic doubt), a conservative procedure can be performed in most of cases.

Entities:  

Mesh:

Year:  1999        PMID: 10233482     DOI: 10.1046/j.1464-410x.1999.00932.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  21 in total

1.  Selective embolization of bleeding renal angiomyolipoma in pregnancy.

Authors:  J Shah; J Jones; M A Miller; U Patel; K M Anson
Journal:  J R Soc Med       Date:  1999-08       Impact factor: 5.344

2.  Association between the growth rate of renal cysts/angiomyolipomas and age in the patients with tuberous sclerosis complex.

Authors:  Jeng-Dau Tsai; Chang-Ching Wei; Shan-Ming Chen; Ko-Huang Lue; Ji-Nan Sheu
Journal:  Int Urol Nephrol       Date:  2014-03-30       Impact factor: 2.370

3.  Surveillance imaging for sporadic renal angiomyolipoma less than 40 mm: lessons learnt and recommendations from the experience of a large district general hospital.

Authors:  K E Chan; Ecp Chedgy; C L Bent; K J Turner
Journal:  Ann R Coll Surg Engl       Date:  2018-04-16       Impact factor: 1.891

4.  Selective arterial embolization of symptomatic and asymptomatic renal angiomyolipomas: a retrospective study of safety, outcomes and tumor size reduction.

Authors:  Florian Bardin; Olivier Chevallier; Aurélie Bertaut; Emmanuel Delorme; Morgan Moulin; Pierre Pottecher; Lucy Di Marco; Sophie Gehin; Eric Mourey; Luc Cormier; Christiane Mousson; Marco Midulla; Romaric Loffroy
Journal:  Quant Imaging Med Surg       Date:  2017-02

5.  Giant renal angiomyolipoma: A case report.

Authors:  Peijie Chen; Lu Jin; Yu Yang; Zebo Chen; Liangchao Ni; Shangqi Yang; Yongqing Lai
Journal:  Mol Clin Oncol       Date:  2017-06-29

Review 6.  Renal artery embolization-indications, technical approaches and outcomes.

Authors:  Arnaud Muller; Olivier Rouvière
Journal:  Nat Rev Nephrol       Date:  2014-12-23       Impact factor: 28.314

Review 7.  Bleeding renal angiomyolipoma presenting as duodenal obstruction.

Authors:  Jeremy Yuen Chun Teoh; Ning Hong Chan; Ho Yuen Cheung; Simon See Ming Hou; Chi-Fai Ng
Journal:  Int Urol Nephrol       Date:  2013-06-18       Impact factor: 2.370

8.  The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1.

Authors:  J Chris Kingswood; Sergiusz Jozwiak; Elena D Belousova; Michael D Frost; Rachel A Kuperman; E Martina Bebin; Bruce R Korf; J Robert Flamini; Michael H Kohrman; Steven P Sparagana; Joyce Y Wu; Thomas Brechenmacher; Karen Stein; Noah Berkowitz; John J Bissler; David N Franz
Journal:  Nephrol Dial Transplant       Date:  2014-04-11       Impact factor: 5.992

9.  Superselective renal artery embolization in the treatment of renal hemorrhage.

Authors:  C Wang; Q Mao; F Tan; B Shen
Journal:  Ir J Med Sci       Date:  2013-06-04       Impact factor: 1.568

10.  Long-term results of preventive embolization of renal angiomyolipomas: evaluation of predictive factors of volume decrease.

Authors:  A Hocquelet; F Cornelis; Y Le Bras; M Meyer; E Tricaud; A S Lasserre; J M Ferrière; G Robert; N Grenier
Journal:  Eur Radiol       Date:  2014-06-03       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.